Your search for ‘Fulbright & Jaworski LLP’ returned 961 results

Nous vous avons déjà parlé quelques fois du projet de loi C-8 visant à bonifier les lois sur la propriété intellectuelle canadiennes (en l’occurence la Loi sur le droit d’auteur et la Loi sur les marques de commerce) pour améliorer l’efficacité de la lutte anti-contrefaçon.

The Federal Court of Appeal has allowed an appeal by Sanofi-aventis et al. ("Sanofi") of a decision declaring Canadian Patent No. 1,336,777 ("777 Patent") to be invalid for lack of utility and obviousness.

The Supreme Court of Canada announced yesterday that it has granted leave to appeal the decision of the Federal Court of Appeal in a proceeding commenced by Apotex.

On January 31, 2014, the Supreme Court of Canada released its decision in 34863 A.I. Enterprises Ltd. et al. v Bram Enterprises Ltd. et al.

On August 16, 2013, Alberta officially released its First Nations Consultation Policy 2013, which will replace the existing policy dated May 16, 2005.

The federal government recently tabled its newly developed Extractive Sector Transparency Measures Act.

J'ai le plaisir de vous présenter aujourd'hui un billet signé Josée Beaudoin, stagiaire au bureau de Montréal.

The Federal Court found that failure to pay the correct "final fee" owing prior to patent grant was not a basis to invalidate a subsequently issued patent.

By a two-to-one majority, the Quebec Court of Appeal recently ruled1 that a finding of the Commission des lésions professionnelles (CLP) according to which a worker had not been the victim of psychological harassment and thus did not suffer an employment injury within the meaning of the Act respecting industrial accidents and occupational diseases

The Canadian Securities Administrators will adopt new rules on permissible pre-marketing and marketing activities in connection with the public offering of securities in Canada.

Previously announced amendments to the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations) were registered and brought into force on June 19, 2015 (the Amendments).

The Federal Court of Appeal released two decisions with respect to proceedings commenced pursuant to the "Patented Medicines (Notice of Compliance) Regulations".

O'Brien involved a proposed products liability class action. The defendants manufactured pelvic mesh products, 19 of which were involved in the proposed class action.

The Law Commission of Ontario (LCO) recently released a list of issues to be considered as part of its comprehensive review of Ontario’s Class Proceedings Act, 1992 (CPA).

On October 31, 2013, the Supreme Court of Canada released its decisions in three related appeals, two from the British Columbia Court of Appeal and one from the Quebec Court of Appeal, all dealing with the certification of price-fixing claims as class actions.

Canada has announced its intention to introduce new legislation mandating the disclosure of payments made by mining companies.

An Alberta court directly disagreed with Ontario decisions on the appropriate factors to consider when a non-resident defendant challenges the jurisdiction of a Canadian court.